A pan-cancer profiling of somatic mutations and tumor microenvironment to reveal mutation dependent immunophenotypic signature differences in KRAS.

e14526Background: The ubiquity of tumor genotyping has identified hundreds of clinically actionable somatic mutations such as KRAS mutations predicting anti-EGFR response in colorectal cancer. Here...